Biden plans to ask Congress to approve $1.1 billion arms sale to Taiwan- Politico
Reuters
Published Aug 29, 2022 07:29PM ET
Updated Aug 29, 2022 09:00PM ET
WASHINGTON (Reuters) -The Biden administration plans to ask the U.S. Congress to approve an estimated $1.1 billion arms sale to Taiwan, including 60 anti-ship missiles and 100 air-to-air missiles, Politico reported on Monday, citing sources, amid heightened tensions with China.
China carried out its largest war games around the democratically governed island after a visit this month by U.S. House Speaker Nancy Pelosi. Beijing has not ruled out using force to bring the island under its control.
China on Monday dismissed complaints from Taiwan about repeated harassment by Chinese drones very close to Taiwanese-controlled islands as not anything "to make a fuss about", prompting Taipei to label Beijing as thieves.
President Joe Biden's administration and U.S. lawmakers stress their ongoing support for the government in Taipei, and there are items in the approval pipeline for Taiwan that could be announced in the coming weeks or months, Reuters reported last week.
But the focus will be on sustaining Taiwan's current military systems and fulfilling existing orders - rather than offering new capabilities more likely to inflame already red-hot tensions with China, according to three sources, who requested anonymity due to the sensitivity of the issue.
The White House did not immediately respond to a request for comment on the Politico report.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.